Cold & Cough Remedies - Central Africa

  • Central Africa
  • In Central Africa, the revenue generated in the Cold & Cough Remedies market market in 2024 amounts to US$83.08m.
  • It is projected that the market will experience an annual growth rate of 6.38% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this market, with US$11,190.00m in 2024.
  • Taking into account the total population figures, in Central Africa, the per person revenue generated in 2024 is US$0.86.
  • The demand for over-the-counter cold and cough remedies in Central Africa has been on the rise due to the region's high prevalence of respiratory infections.

Key regions: United States, Japan, Australia, United Kingdom, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in Central Africa is experiencing significant growth and development due to various factors.

Customer preferences:
Customers in Central Africa have shown a growing preference for over-the-counter cold and cough remedies. This can be attributed to the convenience and accessibility of these products, as well as the increasing awareness and understanding of the benefits of self-medication. Additionally, the affordability of these remedies compared to prescription medications makes them a popular choice among consumers.

Trends in the market:
One of the key trends in the Cold & Cough Remedies market in Central Africa is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious about the ingredients in the products they use and are seeking natural alternatives to traditional medications. This trend is driven by a growing interest in holistic health and wellness, as well as a desire to minimize the potential side effects of synthetic drugs.Another trend in the market is the rising preference for combination products that offer relief from multiple symptoms. Cold and cough often come with a range of symptoms such as congestion, sore throat, and coughing. Consumers are looking for products that can provide comprehensive relief, rather than purchasing multiple individual remedies. Manufacturers are responding to this demand by introducing combination products that target multiple symptoms in a single formulation.

Local special circumstances:
Central Africa has a high prevalence of respiratory infections, which contributes to the demand for cold and cough remedies. The region's tropical climate and dense population create an environment conducive to the spread of respiratory diseases. This has led to a higher incidence of cold and cough among the population, driving the need for effective remedies.Additionally, the lack of access to healthcare facilities in some areas of Central Africa makes over-the-counter remedies a crucial resource for managing common cold and cough symptoms. Many individuals in remote or underserved communities do not have easy access to healthcare professionals or prescription medications. As a result, they rely heavily on over-the-counter remedies to alleviate their symptoms.

Underlying macroeconomic factors:
The growing middle class in Central Africa is a key driver of the Cold & Cough Remedies market. As disposable incomes rise, more consumers are able to afford healthcare products and are willing to spend on self-medication. This has led to increased sales of cold and cough remedies in the region.Furthermore, the improving healthcare infrastructure in Central Africa is contributing to the growth of the market. As more healthcare facilities are established and healthcare services become more accessible, there is a greater emphasis on preventive care and self-management of common illnesses. This has resulted in an increased demand for over-the-counter remedies, including cold and cough products.In conclusion, the Cold & Cough Remedies market in Central Africa is witnessing significant growth and development due to customer preferences for over-the-counter remedies, trends such as the demand for natural and combination products, local special circumstances such as the high prevalence of respiratory infections and lack of access to healthcare facilities, and underlying macroeconomic factors including the growing middle class and improving healthcare infrastructure.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)